AzTrials
AzTrials

Hearing LossNCT04988061

Proactive Counselling Towards Follow-ups in Newborn Hearing Screening

A study testing counselling in people with Hearing Loss and Newborn Morbidity, run by Prince of Songkla University at 1 site in Thailand.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The study aims to investigate if proactive parental educating and counselling can minimize loss to follow-ups of parents whose infant fail newborn hearing screening. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Hearing Loss, Newborn Morbidity
What is being tested?
counselling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteThailand
Study dates
20 Aug 2021to 31 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • The parents whose infants do not pass hearing screening

Who cannot join

  • The parents whose infants have illnesses and are not ready for hearing screening
  • The parents who decide to migrate to other areas

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Faculty of Medicine, Prince of Songkla University

    Hat Yai, Changwat Songkhla, 90110

Other trials in Thailand

About this study

Official title: Result of Proactive Parental Educating and Counselling Towards Follow-ups in Parents Whose Infant Fail Newborn Hearing Screening

The study aims to investigate if proactive parental educating and counselling can minimize loss to follow-ups of parents whose infant fail newborn hearing screening.

Being tested
counselling
Medical subject headings
Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • counsellingOther

    Educating and Counselling with personal communication for 10-15 minutes and written information about the importance of early identification and intervention for hearing loss are provided by a physician. Also, the information about hearing screening results and an appointment date are provided by a physician.

Study groups in NCT04988061
Study groupRoleWhat they receive
Counselling armExperimentalEducating and Counselling are provided by a physician. Also, the information about hearing screening results and an appointment date are provided by a physician.
Receives: Other: counselling
standard armNo interventionThe information about hearing screening results and an appointment date are provided as a routine by either nurses or nurse assistances who perform the screening test.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with loss to follow-ups in all participants whose infants require follow-ups

    A loss to follow-up rate which is calculated from number of participants with loss to follow-ups divided by number of all participants whose infants require follow-ups

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2021
  2. Study start20 Aug 2021
  3. Primary completion31 Jul 2023 (estimated)
  4. Study completion31 Jan 2024 (estimated)

Why it stopped: no subjects enrolled

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04988061
Sponsor's protocol ID
64-220-13-1
Status last verified
Sep 2022
First submitted
28 Jul 2021
Last updated
29 Sep 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing counselling in people with Hearing Loss and Newborn Morbidity, run by Prince of Songkla University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 29 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with loss to follow-ups in all participants whose infants require follow-ups (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in